Labels:monitor | sky | window OCR: NICE-3 Incidence Of non-CABG major bleeding 9% no differences noted those undergoing Incidence historical controls 2% patients WifT ACS treated with 32 inhibitors Enoxaparin appears safe for use in patients who go for Enoxaparir
(.png)
